C
Big Pharma Split Corp. PRM.TO
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)
Weiss Ratings PRM.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Rating C
Reward Index Good
Risk Index Fair
Risk Grade C
Reward Grade B
Rating Factors PRM.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Dividend Index Excellent
Growth Index Good
Efficiency Index Excellent
Solvency Index Excellent
Total Return Index Weak
Volatility Index Fair
Beta / Standard Deviation PRM.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Beta 0.39
Price History PRM.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
7-Day Total Return -0.68%
30-Day Total Return -2.05%
60-Day Total Return 2.89%
90-Day Total Return 5.20%
Year to Date Total Return 1.94%
1-Year Total Return -0.53%
2-Year Total Return 9.69%
3-Year Total Return 8.39%
5-Year Total Return 37.68%
52-Week High % Change -3.32%
52-Week Low % Change 10.23%
Price PRM.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
52-Week High Price $15.05
52-Week Low Price $13.20
52-Week Low Price (Date) Apr 12, 2024
52-Week High Price (Date) Sep 14, 2023
Valuation PRM.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Market Cap 12.12M
Enterprise Value 18.85M
Price/Earnings (TTM) 19.74
Earnings Per Share (TTM) 0.74
Earnings Per Share Growth -525.77%
Price/Earnings To Growth --
Price/Sales (TTM) 6.56
Price/Book (Q) 1.42
Enterprise Value/Revenue (TTM) 7.31
Price $14.55
Enterprise Value/EBITDA (TTM) --
Enterprise Value/EBIT 9.20
Market Cap Category Nano Cap
Dividends and Shares PRM.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Shares Outstanding 1.16M
Dividend Yield 9.01%
Div. Per Share (Most Recent) $0.10
Dividend Per Share (TTM) $1.31
Payout Ratio (TTM) 177.14%
Dividend Per Share (Most Recent) $0.10
Company Info PRM.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Phone Number 416-649-4541
Address 610 Chartwell Road Oakville, ON L6j 4A5
Website www.harvestportfolios.com/closed-end-funds/big-pharma-split-corp/
Country Canada
Year Founded 2017
Profitability PRM.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Operating Margin (TTM) 79.53%
Profit Margin 33.17%
Management Effectiveness PRM.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Return on Assets 6.21%
Return on Equity 6.91%
Income Statement PRM.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Revenue (TTM) --
Total Revenue (TTM) 2.58M
Revenue Per Share $2.22
Gross Profit (TTM) 2.58M
EBITDA (TTM) --
EBIT (TTM) 2.05M
Net Income (TTM) 854.80K
Net Income Avl. to Common (TTM) 477.50K
Total Revenue Growth (Q YOY) 784.09%
Earnings Growth (Q YOY) 314.54%
EPS Diluted (TTM) 0.74
EPS Diluted Growth (Q YOY) 330.44%
Balance Sheet PRM.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Cash and Short-Term Inv. (Q) 1.16M
Cash Per Share (Q) $1.00
Total Current Assets (Q) 1.24M
Total Preferred Equity (Q) --
Total Equity (Q) 11.56M
Current Ratio (Q) 0.143
Book Value Per Share (Q) $10.22
Total Assets (Q) 20.20M
Total Current Liabilities (Q) 8.64M
Total Debt (Q) 7.83M
Total Liabilities (Q) 8.64M
Total Common Equity (Q) 11.56M
Cash Flow PRM.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Cash from Investing (TTM) --
Cash from Financing (TTM) -1.35M
Net Change in Cash (TTM) 879.30K
Levered Free Cash Flow (TTM) 1.85M
Cash from Operations (TTM) 2.23M
Weiss Ratings